The cost of cancer has increased substantially over the years and is continuing to trend upward. During a session at the Oncology Nurse Advisor Navigation Summit, Yousuf Zafar, MD, MHS, an associate professor of medicine and public policy at Duke Cancer Institute, gave some facts and figures on cancer costs and how these are impacting patient well-being.

The estimated cancer prevalence by age in the United States is expected to increase from 216 million in 1975 to 380 million in 2040. With older cancer survivors, the severity of disease and treatment will increase, and the physiologic effects of aging, such as pre-existing conditions and new-onset morbidity, will impact the level of care needed for older adults.

Increasing healthcare expenses have become a major concern for patients with cancer, especially considering the cost of oncology medications and treatment plans. On Friday, February 26, ONS President-Elect Susan Schneider, PhD, RN, AOCN®, FAAN, participated in a discussion titled “Exploring Innovative Strategies to Mitigate Cost-Sharing Burdens for Patients” at the event Cost-Sharing Roundtable: Improving Patient Access to Critical Therapies hosted by the Patient Access Network (PAN) and the American Journal of Managed Care in Washington, DC.